[home]
[thesaurus]
Click Here to return To Results
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
Stroke 39:1482-1486,1406, Healey,J.S.,et al, 2008
See this aricle in Pubmed
Article Abstract
In this clinical trial, patients with a CHADS2 =1 had a low risk of stroke, yet still derived a modest (<1% per year) but statistically significant absolute reduction in stroke with OAC and had low rates of major hemorrhage on OAC.
Related Tags
(click to filter results - removes previous filter)
adverse drug reaction
anticoagulant,treatment in CVD
antihypertensive
aspirin
atrial fibrillation
atrial fibrillation,risk stratification
cerebrovascular accident,prevention of
CHADS2
clopidogrel
coumarin
Irbesartan
platelet inhibiting drugs
platelet inhibiting drugs,combined
practice guidelines
prevention of neurologic disorders
risk-benefit assessment
Click Here to return To Results